Muscarinic receptor type-3 (MR3) in hypertension and cholinergic-adrenergic crosstalk: genetic insights and potential for new antihypertensive targets

Alves-Lopes, R., Neves, K. B. and Touyz, R. M. (2019) Muscarinic receptor type-3 (MR3) in hypertension and cholinergic-adrenergic crosstalk: genetic insights and potential for new antihypertensive targets. Canadian Journal of Cardiology, 35(5), pp. 555-557. (doi:10.1016/j.cjca.2019.02.003) (PMID:30954389) (PMCID:PMC6499128)

[img]
Preview
Text
180216.pdf - Published Version
Available under License Creative Commons Attribution.

392kB

Abstract

No abstract available.

Item Type:Articles (Editorial)
Additional Information:RMT is supported by a British Heart Foundation (BHF) Chair award (CH/4/29762). KBN and RAL are supported by the BHF Award of Research Excellence (RE/13/5/30177).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Neves, Dr Karla and Touyz, Professor Rhian
Authors: Alves-Lopes, R., Neves, K. B., and Touyz, R. M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Canadian Journal of Cardiology
Publisher:Elsevier
ISSN:0828-282X
ISSN (Online):1916-7075
Published Online:13 February 2019
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in Canadian Journal of Cardiology 35(5):555-557
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
607381Vascular Noxs as therapeutic targets and biomarkers in hypertensionRhian TouyzBritish Heart Foundation (BHF)CH/12/4/29762RI CARDIOVASCULAR & MEDICAL SCIENCES
617771BHF centre of excellenceRhian TouyzBritish Heart Foundation (BHF)RE/13/5/30177RI CARDIOVASCULAR & MEDICAL SCIENCES

Downloads per month over past year

View more statistics